Deploying a new commercial intelligence platform is a significant investment in technology, time, and in the trust of the field teams expected to use it every day.

Getting that deployment right matters. Not just at go-live, but in the weeks that follow, when the training room is empty and reps are back in their territories making real decisions under real pressure.

We've worked with pharmaceutical sales teams across North America through pilot phases, go-live, and long after. What we've seen consistently: the technology is only part of the equation. MIT found that 95% of AI initiatives fail, and the driving force behind most of those failures is implementation, not the platform itself.

When a field team doesn't trust a new tool, they don't use it. They fall back on what they know, even if what they know is slower, less accurate, and increasingly out of date. The technology is there. The behavior change isn't.

At ODAIA, we know we have one shot to get a deployment right and we take that seriously. We've spent years watching what separates the rollouts that stick from the ones that stall. Thousands of pharma reps use our platform to educate healthcare professionals and help patients get to the right therapies faster. That's not just a testament to our technology — it's a testament to the way we align and launch our tool to end-users.

Our Approach: Multi-Threaded From Day One

Most software rollouts are designed around the product. Ours are designed around the people using it. Before a single training session runs, we work to understand the organization; who the end-users are, where friction is likely to surface, and how to build alignment from head office down to the field.

Start with the people, not the platform.

We conduct end-user interviews and engage in multi-threaded strategy across both head office and field teams before launch. We want to understand where friction lives before it shows up in the field.

Empower champions to lead.

Our training approach empowers internal champions to lead peer-to-peer learning and support pre- and post-launch education, driving a high-touch approach that reduces friction to adoption.

Build readiness before go-live.

In parallel, we build out self-paced online modules tailored to each partner's setup, working with L&D teams where they exist and standing in for that function where they don't. Field reps get early exposure to the platform along with quizzes to reinforce their learning before go-live. By the time they're in the training room, it's not the first time they've seen the platform.

The table below illustrates how this differs from a standard software rollout:

Learning From the People Who Use it Everyday

One of the most effective things we do in a launch isn't a feature demo or a slide deck, it's getting reps in front of other reps. People trust the experience of someone in their role more than any marketing claim about what a tool can do.

At a recent National Sales Meeting, we implemented a full day of training with an emphasis on the end-users themselves. We hosted a panel of pharma sales reps who participated in our pilot and let them tell their story.

"The panel interview, with the pilot team, was such a meaningful addition and brought authenticity, reassurance, and practical insights. We really feel that was exactly what they needed to feel more confident and comfortable navigating through such a significant transition."

Peer-to-peer learning is so important because it builds trust and confidence. Who better than someone who knows your daily workflow to show you the ropes. Embedded in these panels are real case studies that demonstrate value, not just marketing claims about AI.

Our panelists spoke about how they found new healthcare professionals to educate, how they detailed the right product at the right time, and how they came into the conversation prepared with insights from ODAIA Field Intelligence.

We also hosted breakout workshops where reps teach back what they learned during earlier training sessions, reinforcing key concepts while learning from one another.

For more stories like this, explore our customer showcase.

Continuity: The Part Most Programs Get Wrong

A successful deployment creates momentum. What determines whether that momentum holds is what happens in the weeks that follow, when territory pressure is back and old habits are easy to fall back on. This is where most programs lose ground, and why continuity matters as much as the go-live itself.

Our Business Acceleration team follows every deployment with ongoing support: office hours, personalized training sessions, and scenario-based coaching tied to real territory situations. There's a temptation to focus training entirely on feature coverage — here's what the dashboard shows, here's how to filter, here's the report you need. That approach produces users who know where to click. It doesn't produce users who feel ready.

Psychological readiness matters more than functional competence in high-autonomy roles. Sessions designed to meet pharma reps where they are look different:

• Scenario-based learning anchored in real territory situations, not generic use cases
• Manager alignment sessions run in parallel, so reps aren't the only ones who understand the new workflow
• Deliberate space for questions and concerns because a concern raised openly is a concern that can actually be addressed

When end users are genuinely confident, the impact compounds. Data is richer and more consistent. Insights are acted on more readily. Adoption curves steepen. The return on investment grows and the platform becomes a genuine competitive advantage, rather than another tool reps work around.

What Launch Excellence Actually Looks Like

Ultimately, this is about respecting the people on the other end of the deployment. Pharma reps spend their careers helping healthcare providers find the right options for their patients. The least we can do is meet them with the same standard: clear, honest guidance through a real transition.

When we get that right, a sales force leaves a National Sales Meeting with more than knowledge. They leave with a clear path forward. A team that knows exactly what to do on Monday morning.

That's what launch excellence looks like and it's what we bring to every deployment, from initial rollout through to long-term adoption. See how it plays out in practice in our customer case studies.

Where to Go From Here

Whether you're evaluating a new platform or trying to get more out of one already in place, these are good next steps:

• The Commercial AI Blueprint for Pharma: A practical playbook for aligning brand strategy with field execution, and proving impact fast.
• AI Readiness Assessment for Commercial Pharma Teams: A checklist built for commercial leaders evaluating their organization's readiness before a platform decision.
• Book a Discovery Call: Tell us about your current setup. We'll show you where ODAIA fits and what getting started actually looks like.